Immunovant, Inc.

By person

18 insiders · 2 transactions

17.2×

Eric Venker holds 17.2 times base salary in stock. $11.00M of shares against $636.62K in salary for 2026.

Salary from the company's own proxy. The shares are what Eric Venker last reported holding, valued at $43.27, the price Common Stock was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gloria Melanie

Chief Operating Officer

—

$134.95K (1)

−$134.95K

219,301

0.1062%

$9.49M

—

Pande Atul

Director

—

$64.91K (1) scheduled

−$64.91K

116,731

0.0565%

$5.05M

+23.6%

Roivant Sciences Ltd. entity

Director

—

113,317,007

54.86%

$4.90B

+42.0%

Salzmann Peter

Chief Executive Officer

—

1,178,191

0.5704%

$50.98M

+16.8%

Torti Frank

Director

—

1,009,228

0.4886%

$43.67M

+58.8%

Barnett Eva Renee

Chief Financial Officer

—

396,774

0.1921%

$17.17M

+15.4%

Macias William L.

Chief Medical Officer

—

357,353

0.1730%

$15.46M

−3.0%

Levine Mark S.

Chief Legal Officer

—

319,228

0.1546%

$13.81M

−3.3%

Venker Eric

Chief Executive Officer

—

254,280

0.1231%

$11.00M

—

Girao Tiago

Chief Financial Officer

—

240,798

0.1166%

$10.42M

—

Geffner Michael

Chief Medical Officer

—

217,958

0.1055%

$9.43M

+57.8%

Stout Jay S

Chief Technology Officer

—

205,341

0.0994%

$8.89M

+41.7%

Van Tuyl Christopher

Chief Legal Officer

—

179,391

0.0868%

$7.76M

—

MIGAUSKY GEORGE V

Director

—

137,251

0.0664%

$5.94M

+13.4%

Hughes Douglas J.

Director

—

134,653

0.0652%

$5.83M

+7.7%

Fromkin Andrew J.

Director

—

74,382

0.0360%

$3.22M

−25.6%

Bauer Jake

Director

—

38,896

0.0188%

$1.68M

—

Susman Robert Graham

Director

—

36,394

0.0176%

$1.57M

—

By person

Individual transactions

What was left out